The ASM is taking a proactive role in this regard. Second, even as we strive to prevent bioterrorism, we must candidly recognize that no set of regulations can provide absolute assurance that no act of bioterrorism will ever occur. Therefore, as we strive to prevent such acts, we also have a duty to pursue research and public health improvements aimed at developing the most effective possible responses to acts of biological terror. Research and public health responses related to effectively combating an act of terror are a critical component of the public policy response to the threat that exists. Third, while the possibility of a future act of biological terrorism is a terrible threat with which we must and will deal, the scourge of infectious diseases is a terrible reality that daily takes the lives of thousands of Americans and tens of thousands around the world.
Infectious diseases are now the third leading cause of death in the United States.
Research on the prevention and treatment of such diseases is critical to the well being of our entire population. In responding to the threat of terror, therefore, we must minimize any adverse impact upon vital clinical and diagnostic research related to infectious diseases. Congress and federal agencies have appreciated these competing considerations and have sought to minimize interference with research through such measures as recognizing appropriate exemptions in regulating the handling of pathogenic microorganisms. As we have stated, past legislation has recognized the need for balancing these concerns. We know that such balancing will continue, and the ASM is committed to providing all available assistance in achieving balanced and effective responses to the threat to the public welfare.